Distress and Care Utilization in Patients with Myeloproliferative Neoplasms
Acta Haematologica · 2025
DOI: 10.1159/000544162 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Haematologica, 2025. Verfasst von Rushil Patel und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina, USA. Hauptthemen laut MEDLINE: Myeloproliferative Disorders, Patient Acceptance of Health Care, Psychological Distress. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Introduction
Distress negatively affects cancer outcomes. The National Comprehensive Cancer Network (NCCN) recommends screening patients for distress by a self-reported scale (0–10) and referring those with scores ≥4 to supportive services (SSs). Little is known about the prevalence of distress and healthcare utilization in classical Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs): polycythemia vera (PV), essential thrombocythemia (ET), myelofibrosis (MF).
Methods
We retrospectively identified MPN patients at our center to measure the proportions of patients with distress ≥4 evaluated by a SS (chaplaincy, integrative oncology, palliative medicine, psychiatry, psychology, and social work [SW]) or had acute care utilization (ACU; ≥ 1 ED visit or hospitalization) within 6 months of electronic distress screening (EDS). We also obtained sociodemographic, disease characteristics, and symptom score data to stratify variables associated with distress.
Results
Among 141 patients (44 PV, 49 ET, and 48 MF), the median age was 63 years (range, 25–89). Most patients identified as female (62%), white (77%), and completed EDS within 3 months of diagnosis (55%). Of 75/141 (53%) who reported distress ≥4, only 25/75 (33%) were evaluated by SS, and 23/75 (31%) had ACU within 6 months of EDS. Patients with distress ≥4 evaluated by SS had significantly higher ACU (48% vs. 14%; p = 0.009). Distress was associated with higher symptom scores and more ED visits but not gender, race, ethnicity, diagnosis, relationship status, or insurance.
Conclusion
Despite consensus recommendations, most patients with distress ≥4 were not evaluated by SS. Future work should identify ways to better use patient-reported outcomes to promote early intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina, USA.
- Department of Cancer Biostatistics, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina, USA.
- Department of Supportive Oncology, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina, USA.
- Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, USA.
Zitieren
APA
Patel, R., Patel, R. V., Boselli, D., Meadors, P. L., Begley, S., Bose, R., Ai, J., Ragon, B. K., Sanikommu, S., Shah, N., Knight, T., Symanowski, J. T., Walsh, D., Mesa, R. A., Grunwald, M. R., & Chojecki, A. (2025). Distress and Care Utilization in Patients with Myeloproliferative Neoplasms. Acta Haematologica. https://doi.org/10.1159/000544162
Vancouver
Patel R, Patel RV, Boselli D, Meadors PL, Begley S, Bose R, et al. Distress and Care Utilization in Patients with Myeloproliferative Neoplasms. Acta Haematologica. 2025. doi:10.1159/000544162
BibTeX
@article{Patel2025,
author = {Patel, Rushil and Patel, Rushil Virendra and Boselli, Danielle and Meadors, Patrick L and Begley, Stephanie and Bose, Rupali and Ai, Jing and Ragon, Brittany Knick and Sanikommu, Srinivasa and Shah, Nilay and Knight, Thomas and Symanowski, James T and Walsh, Declan and Mesa, Ruben A and Grunwald, Michael R and Chojecki, Aleksander},
title = {Distress and Care Utilization in Patients with Myeloproliferative Neoplasms},
journal = {Acta Haematologica},
year = {2025},
doi = {10.1159/000544162}
}
EUVIMED